Swine flu pandemic review panel seeks access to confidential documents between WHO and drug companiesBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2792 (Published 25 May 2010) Cite this as: BMJ 2010;340:c2792
- John Zarocostas
The chairman of the external expert review committee examining the World Health Organization’s management of the H1N1 pandemic said the panel wants access to confidential documents between the agency and drug companies.
Harvey Fineberg, the head of the 29 member review committee, told reporters at the annual World Health Assembly, “We are aware we will want to have access to certain confidential documents that may be in place here at WHO, or elsewhere.”
Mr Fineberg, who is also president of the Institute of Medicine in Washington, added that, “Some of the agreements with industry that we would like to examine have been considered confidential.”
These documents include “contractual or letters of understanding with (the pharmaceutical) industry that have been considered private communications,” he said.
Dr Fineberg’s remarks …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.